Anatara Lifesciences Ltd has released a press release.
Entitlement Offer Prospectus
Filed with ASX ·
6ix hasn’t read this filing yet.
Anatara Lifesciences Ltd on 6ix
Earlier from Anatara Lifesciences
- Anatara Investor Presentation
- 3FDC Clinical Trial update
- Appendix 4E & Audited Financial Report 30 June 2022
- Operational Update
- Q4 FY22 Activities Report
Later from Anatara Lifesciences
- Appendix 4C & Q1 FY23 Activities Report
- Completion of Non-renounceable Entitlement Offer and Shortfa
- Appendix 4C & Q2 FY23 Activities Report
- Revised Appendix 4C
- Placement of Shortfall from Entitlement Offer
Follow Anatara Lifesciences into a list and get an email when it puts out news.
Follow Anatara Lifesciences